Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1802658 Title: ANTICORPS MONOCLONAUX, CHIMERIQUES, HUMANISES CONTRE L'INTERLEUKINE 13

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
057570244
WO application number:
GB2005002581
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
1802658
WO publication number:
WO 2006/003407
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
30/06/2005
Grant date:
30/11/2011
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
23/02/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
30/11/2011
EP B1 publication date:
30/11/2011
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2018
Expiration date (if granted and all annual fees paid):
30/06/2025

Applicant

Name:
GLAXO GROUP LIMITED
Legal Form:
From:
30/11/2011
Address:
Glaxo Wellcome House Berkeley Avenue, Greenford Middlesex UB6 0NN, United Kingdom (GB)
To:

Agent

1

Name:
OFFICE KIRKPATRICK S.A.
Legal Form:
From:
23/12/2020
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

2

Name:
FRENNET Pierre-Paul
Legal Form:
From:
23/02/2012
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:
23/12/2020

Inventor

1

Name:
ASHMAN, Claire GlaxoSmithKline Gunnels Wood Road
Legal Form:
Address:

2

Name:
CASSIDY, Martin John GlaxoSmithKline
Legal Form:
Address:

3

Name:
ELLIS, Jonathan Henry GlaxoSmithKline
Legal Form:
Address:

4

Name:
WATTAM, Trevor Anthony Kenneth GlaxoSmithKline
Legal Form:
Address:

Priority

1

Priority patent number:
0414799
Priority date:
01/07/2004
Priority country:
United Kingdom (GB)

2

Priority patent number:
0423675
Priority date:
25/10/2004
Priority country:
United Kingdom (GB)

Classification

Main IPC class:
C07K 16/24;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2011/11
Publication date:
30/11/2011
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2019/04
Publication date:
06/03/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
14/06/2017
Last annual fee paid number:
13
Last annual fee paid amount:
275 Euro
Payer:
NOVAGRAAF INTERNATIONAL SA
Filing date Document type Publication Type Document Description Number of pages File Type
23/02/2012 General Document (TP - T:Traduction Originale plus Pouvoir) 212 PDF /8/5/6/2/0/0611802658/migrated-docs/057570244_1_288612.pdf
23/12/2020 Request For Change Letter and/or Form requesting a change in the Register 6 PDF /8/5/6/2/0/0611802658/docs/057570244_1_rfc_20201223_040513906.pdf